Piperoxan

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C14H19NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9ZCS27634Y, chemically known as 1,4-benzodioxane, 2-(piperidinomethyl)- but generally known as piperoxan, which bears US NIH Compound Identifier 6040. European Medicines Agency schedules Piperoxan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09872MIG. The term PIPEROXAN is an International Non-Proprietary Name. PIPEROXAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule piperoxan under HS 29349990 and SITC 51579. As of Q4 2014, PIPEROXAN remains the US FDA Preferred Term for this commodity. Piperoxan bears US NLM identifiers UMLS ID C0031963 and NCI Concept Code C66399. SMILES: O1C(CN2CCCCC2)COC2C1CCCC2.